{
    "code": "02025748",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025748",
    "time": "2019-04-19 03:30:47",
    "許可證字號": "衛署藥輸字第025748號",
    "註銷狀態": "已註銷",
    "註銷日期": "108\/03\/14",
    "註銷理由": "未展延而逾期者",
    "有效日期": "106\/07\/06",
    "發證日期": "101\/07\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202574808",
    "中文品名": "保止栓膜衣錠75毫克",
    "英文品名": "Clopidogrel-Teva 75mg Film-coated Tablets",
    "適應症": "降低近期發生中風、心肌梗塞或周邊動脈血管疾病的粥狀動脈硬化病人之粥狀動脈栓塞事件(如：心肌梗塞、中風或其他因血管病變引起的死亡)的發生。與ASPIRIN併用降低非ST段上升之急性冠心病(不穩定性心絞痛和非Q波型心肌梗塞)病人(包括經皮冠狀動脈介入性治療後放置支架的患者)之粥狀動脈栓塞事件。與ASPIRIN併用可用於以內科治療的ST段上升之急性心肌梗塞病人。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "CLOPIDOGRELHYDROGENBISULFATE"
    ],
    "限制項目": "02輸　入 1Q不得輸入 24監視期滿學名藥 61完成BE試驗",
    "申請商名稱": "1011101100  海喬國際股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F240011100  TEVA PHARMACEUTICAL INDUSTRIESLIMITED (KFAR SAVA PLANT)",
        "製造廠廠址": "64 HASHIKMA STREET, KFAR SAVA 44102, ISRAEL",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012600240",
            "成分名稱": "CLOPIDOGREL HYDROGEN BISULFATE",
            "含量描述": "(Equivalent to Clopidogrel 75mg)",
            "含量": "97.8750000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "02025748001-10408-保止栓膜衣錠仿單-104-12-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025748&Seq=002&Type=9"
        },
        {
            "title": "Clopidogrel box___20121105.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025748&Seq=003&Type=8"
        }
    ]
}